InnoCare Pharma Limited (OTCMKTS:INCPF) Short Interest Up 34.7% in April

InnoCare Pharma Limited (OTCMKTS:INCPF) was the target of a large increase in short interest in the month of April. As of April 15th, there was short interest totaling 3,844,879 shares, an increase of 34.7% from the March 31st total of 2,855,382 shares. Based on an average trading volume of 0 shares, the short-interest ratio is presently ∞ days.

InnoCare Pharma Price Performance

Shares of OTCMKTS:INCPF remained flat at $1.55 during mid-day trading on Thursday. InnoCare Pharma has a 1 year low of $1.55 and a 1 year high of $2.31. The company’s 50 day moving average price is $1.57 and its 200 day moving average price is $2.06.

InnoCare Pharma Company Profile

InnoCare Pharma Ltd is a China-based, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small-molecule targeted therapies for oncology. Headquartered in Shenzhen, Guangdong Province, the company leverages structure-based drug design and comprehensive preclinical screening to advance drug candidates that address high-unmet-need cancers.

The company’s development pipeline comprises multiple small-molecule inhibitors in various stages of preclinical and early clinical evaluation.